Advertisement
Abstract| Volume 18, ISSUE 6, SUPPLEMENT , S8, June 2016

BM-MSC Accelerates Acute Stroke Recovery in a Randomized Placebo-Controlled Clinical Phase II/III Study

      Background: We previously demonstrated that mesenchymal stromal cell (MSC) may be transdifferentiated into neuron-like cells. MSC may also help attenuate cerebral oedema and hasten recovery following acute stroke. Furthermore, the blood-brain barrier is semipermeable in the acute stroke period which allows MSC to be administered intravenously.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect